Validation Study of Combined Positron Emission Tomography/Computer Tomography to Diagnose Infection and Inflammation

NCT ID: NCT00835783

Last Updated: 2014-10-28

Study Results

Results pending

The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.

Basic Information

Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.

Recruitment Status

TERMINATED

Total Enrollment

30 participants

Study Classification

OBSERVATIONAL

Study Start Date

2008-11-30

Study Completion Date

2013-12-31

Brief Summary

Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.

The overall aim is to validate the current use of FDG PET/CT for the diagnosis of infection and inflammation and examine the usefulness of PET/CT applying also other tracers.

The results should allow us to confirm our primary hypothesis: "FDG-PET/CT is better than established methods to confirm or exclude the diagnosis of infection/inflammation".

Detailed Description

Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.

The study include several part projects, each contributing to the evaluation of the value of FDG-PET/CT in the diagnosis of infection and inflammation. The aims are to establish the diagnostic value in terms of sensitivity, specificity, positive and negative predictive values, interobserver and intraobserver variation.

Part project A FDG-PET/CT in patients with blood culture positive for staphylococcus aureus and unresolved origin of infection.

Part project B FDG-PET/CT in patients with fever of unknown origin.

Part project C FDG-PET/CT in patients suspected of vascular graft infection.

Additionally, we wish to establish an optimal imaging protocol (necessity of fasting, consequences of antibiotic therapy prior to imaging, and the need of contrast), interpretation criteria, and the value of standard uptake values (SUV).

Conditions

See the medical conditions and disease areas that this research is targeting or investigating.

Bacterial Infections Bacteremia Gram-Positive Bacterial Infections Inflammation

Study Design

Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.

Observational Model Type

CASE_ONLY

Study Time Perspective

PROSPECTIVE

Study Groups

Review each arm or cohort in the study, along with the interventions and objectives associated with them.

FUO

Patients with fever of unknown origin undergoing FDG-PET/CT as part of work-up.

No interventions assigned to this group

BUO

Patients with bacteremia of unknown origin undergoing FDG-PET/CT as part of work-up.

No interventions assigned to this group

VGI

Patients with vascular graft infections undergoing FDG-PET/CT as part of work-up.

No interventions assigned to this group

Eligibility Criteria

Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.

Inclusion Criteria

Part project A

• Blood culture positive for staphylococcus aureus and unresolved origin of infection.

Part project B

* Fever of unknown origin
* Referred for FDG-PET/CT at the Department of Nuclear Medicine, Odense University Hospital.

Part project C

* Suspected vascular graft infection
* Referred for FDG-PET/CT at the Department of Nuclear Medicine, Odense University Hospital.

Exclusion Criteria

* Patients incapable of giving, refusing or revoking consent
* Patients less than 18 years of age
* Patients from other regions than the Region of Southern Denmark
* Patients who cannot cooperate to PET/CT scan.
Minimum Eligible Age

18 Years

Eligible Sex

ALL

Accepts Healthy Volunteers

No

Sponsors

Meet the organizations funding or collaborating on the study and learn about their roles.

Odense University Hospital

OTHER

Sponsor Role lead

Responsible Party

Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.

Søren Hess, MD

MD

Responsibility Role PRINCIPAL_INVESTIGATOR

Principal Investigators

Learn about the lead researchers overseeing the trial and their institutional affiliations.

Søren Hess, MD

Role: PRINCIPAL_INVESTIGATOR

Odense University Hospital, Dept. of Nuclear Medicine

Locations

Explore where the study is taking place and check the recruitment status at each participating site.

Odense University Hospital, Dept. of Nuclear Medicine

Odense, , Denmark

Site Status

Countries

Review the countries where the study has at least one active or historical site.

Denmark

Other Identifiers

Review additional registry numbers or institutional identifiers associated with this trial.

105-K20

Identifier Type: -

Identifier Source: org_study_id

More Related Trials

Additional clinical trials that may be relevant based on similarity analysis.

PET/CT Imaging in COVID-19 Patients
NCT04376593 ENROLLING_BY_INVITATION EARLY_PHASE1
FDG-PET Imaging in Complicated Diabetic Foot
NCT00194298 ACTIVE_NOT_RECRUITING
CUP Project PET/CT
NCT01469026 UNKNOWN PHASE4